1996•PubMedRequires access

[Cholecystokinin receptors. A target for tomorrow's psychopharmaceuticals?].

Olof Zachrisson, Nils Lindefors

Abstract

The neuropeptide cholecystokinin (CCK) and its receptors are highly expressed in brain regions important for cognitive functions, emotions and the initiation of movements. Two high-affinity receptors exist for CCK, the A-and B-type. A number of ligands are developed for these receptors. Evidence for the involvement of CCK and its receptors in the pathofysiology of neuropsychiatric disorders is discussed. In addition, we discuss the possible use of CCK receptors ligands in the treatment of such disorders.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Cholecystokinin, Receptor, Cholecystokinin receptor, Neuropeptide, Neuroscience, Class C GPCR, G protein-coupled receptor, Chemistry